Yosuke Matsumoto

Frequent <i>PVT1</i> Rearrangement and Novel Chimeric Genes <i>PVT1-NBEA</i> and <i>PVT1-WWOX</i> Occur in Multiple Myeloma with 8q24 Abnormality

Hisao Nagoshi, Tomohiko Taki, Ichiro Hanamura et al. · Cancer Research · 2012 · 101 citations

Medicine, Genetics, Oncology +9

Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia

Mio Yamamoto‐Sugitani, Junya Kuroda, Eishi Ashihara et al. · Proceedings of the National Academy of Sciences · 2011 · 100 citations · Full text

Medicine, Cell Biology, Oncology +15

ABT‐737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug‐resistance mechanisms

Junya Kuroda, Shinya Kimura, Michael Andreeff et al. · British Journal of Haematology · 2007 · 84 citations

Medicine, Oncology, Pharmacology +17

Successful Treatment with Erwinia l -Asparaginase for Recurrent Natural Killer/T Cell Lymphoma

Yosuke Matsumoto, Ken-ichi Nomura, Yumiko Kanda-Akano et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 57 citations

Medicine, Hematology, Oncology +17

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

Tomoko Iehara, Hajime Hosoi, Kohei Akazawa et al. · British Journal of Cancer · 2006 · 46 citations · Full text

Medicine, Oncology, Pediatrics +13